Author:
Zou Juan,Li Yuanyuan,Cai Jingyi,Peng Xiaotian,Zhang Lincong,Tian Tian,Wang Tianming,Shi Rong,Wu Jiasheng,Ma Yueming
Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Reference38 articles.
1. P, Santiago, A.R, Scheinberg, C, Levy, Cholestatic liver diseases: new targets, new therapies, Ther. Adv. Gastroenterol, 11 2018 1756284818787400.
2. The management of cholestatic liver diseases: current therapies and emerging new possibilities;Mazzetti;J. Clin. Med.,2021
3. Prevalence and risk factors of intrahepatic cholestasis of pregnancy in a Chinese population;Gao;Sci. Rep.,2020
4. Guidelines for the Management of Cholestatic Liver Diseases 2021;Lu;J. Clin. Transl. Hepatol.,2022
5. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC);Mattner;Int. J. Mol. Sci.,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献